Navigation Links
Biopure Granted Additional 180 Day Compliance Period by NASDAQ
Date:6/12/2008

CAMBRIDGE, Mass., June 12 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that The NASDAQ Stock Market has granted the Company an additional 180 days, or until December 8, 2008, to regain compliance with Marketplace Rule 4310(c)(4) requiring a minimum bid price of $1.00 for continued listing. Currently, the Company meets all other required inclusion criteria for the NASDAQ Capital Market. If, at any time before December 8, 2008, the bid price of the Company's common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Company will be provided written notification that it complies with the Marketplace Rule.

If compliance with the Marketplace Rule cannot be demonstrated by December 8, 2008, NASDAQ will issue a delisting notice to the Company.

Biopure Corporation

Biopure Corporation develops, manufactures and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. Hemopure(R) [hemoglobin glutamer - 250 (bovine)], or HBOC-201, is approved for sale in South Africa for the treatment of surgical patients who are acutely anemic. The company is developing Hemopure for other indications and is supporting the U.S. Navy's government-funded efforts to develop a potential out-of-hospital trauma indication. Biopure's veterinary product Oxyglobin(R) [hemoglobin glutamer - 200 (bovine)], or HBOC-301, the only oxygen therapeutic approved for marketing by both the U.S. Food and Drug Administration and the European Commission, is indicated for the treatment of anemia in dogs. Biopure has sold approximately 200,000 units of Oxyglobin since its launch.

Tiana Gorham

Biopure Corporat
'/>"/>

SOURCE Biopure Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Biopure Announces MHRA Meeting Update
2. Biopure Announces 2008 Second Quarter Financial Results
3. Biopure Appoints Dechra Exclusive U.S. Distributor of Oxyglobin
4. Biopure Announces Date to Meet with UKs Medicines and Healthcare Products Agency
5. Biopure Operations Compliant With U.K. Manufacturing Guidelines
6. Biopure Appoints New Independent Auditor
7. Biopure Completes U.K. Regulatory Agency Inspection
8. Biopure Announces 2008 First Quarter Financial Results
9. Biopure Launches Updated Website
10. Biopure Announces Pricing of Equity Offering
11. Biopure Gives Update on Malaysia Joint Venture Discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... at Hahnemann among the Best in the Nation ... University Hospital proudly announces it has been granted ... (ANCC) Magnet Recognition Program(R). Magnet(R) is one of ... medical center can achieve, and places Hahnemann among ... that have achieved this prestigious distinction. ,, At ...
(Date:12/16/2009)... biotechnology company,s revenues increase 22% for fiscal 2009; ... 2010 , TORONTO, Dec. 16 /PRNewswire-FirstCall/ - Microbix ... virology and biological technologies, today reported financial results ... fiscal year ended September 30, 2009, Microbix reported ... the same period in 2008. For fourth-quarter 2009, ...
(Date:12/16/2009)... Nu-Tek BioSciences, LLC introduces HSP-A Soy Peptone. HSP A has ... , ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, ... by introducing HSP-A Soy Peptone. HSP-A, previously manufactured by Nutricepts, ... is proven to improve growth rates and yields. HSP-A has ...
(Date:12/15/2009)... Sky One,Medical, Inc. ("China Sky One Medical" or ... integrated pharmaceutical company developing and producing,over-the-counter drugs in ... the Company has 30 medicines that will be ... Medical Insurance, Industrial Injury Insurance,and Maternity Insurance Medicine ... medicines treat a variety of common ailments and ...
Breaking Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3Microbix' Pipeline Set To Reach Milestones In 2010 2Microbix' Pipeline Set To Reach Milestones In 2010 3Microbix' Pipeline Set To Reach Milestones In 2010 4Microbix' Pipeline Set To Reach Milestones In 2010 5Microbix' Pipeline Set To Reach Milestones In 2010 6Microbix' Pipeline Set To Reach Milestones In 2010 7Microbix' Pipeline Set To Reach Milestones In 2010 8China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3
... manufacturing facility opening in Second Quarter,TORONTO, Feb. 13 ... that despite a challenging year for the biopharmaceutical ... its advance toward the ultimate goal of sustained ... first quarter ended December 31, 2008. , In ...
... MISSISSAUGA, ON, Feb. 13 /PRNewswire-FirstCall/ - YM BioSciences ... company that identifies, develops and commercializes differentiated products ... results for the second quarter of fiscal 2009, ... we prepared to initiate our two randomized Phase ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ), a developmental ... and several late stage preclinical programs,announced today the appointment ... , Robert W. Duggan, our ... the,company after acting as interim CEO for the past ...
Other Biology Technology:Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 2Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 3Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline 4YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 2YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 3YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 4YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 5YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 6YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 7YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 8YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 9YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS 10Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth 2Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth 3Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth 4Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth 5Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth 6
(Date:12/16/2009)... GestureTek Inc. today announced the ... a turnkey, portable, plug and play interactive ... and touring promotions. GestureTek is the inventor ... camera-enabled gesture recognition technology for interactive display, ... quality, the CUBE has TUV, CE, CSA ...
(Date:12/16/2009)... AUSTIN, Texas, Dec. 8, 2009 ... leader in industrial measurement and control, and ... manufacturing automation using robotics technology, today announced ... vision technology with DENSO robotic arms. The ... test, research and flexible manufacturing applications. In ...
(Date:12/15/2009)... are born, they are susceptible to diseases and infections, ... month, their immune systems aren,t adequately developed to fight ... lead to serious problems if left untreated. To help ... pinpointed a group of depleted white blood cells, which ... to improve the immune system of newborns to make ...
Breaking Biology News(10 mins):GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 2National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 3National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 4National Instruments and DENSO Robotics Collaborate to Address New Applications in Industrial Robotics 5Researchers work on vaccine to improve immune system in newborns 2Common variation in gene linked to structural changes in the brain 54682 1Common variation in gene linked to structural changes in the brain 54682 2Strep Throat May Have Led to Mozarts Death 54678 1Strep Throat May Have Led to Mozarts Death 54678 2Strep Throat May Have Led to Mozarts Death 54678 3Synthetic Protein Thwarts HIV Infection in Lab 54673 1Synthetic Protein Thwarts HIV Infection in Lab 54673 2
... and Nanotechnology (IBN) have succeeded in unlocking the potential ... by converting it into a more useful product. ... , the IBN researchers report that by using organocatalysts, ... process to produce methanol, a widely used industrial feedstock ...
... to the brain is restricted. Initially, brain cells die ... inflammatory processes in the affected area of the brain. ... at Heidelberg University Hospital have shown that certain immune ... These cells are known as regulatory T lymphocytes (Treg). ...
... RIVERSIDE, Calif. A researcher at UC Riverside has discovered a ... moss or a dry leaf and named it after President ... doing a survey for lichen diversity on Santa Rosa Island in ... Herbarium . "I named it Caloplaca obamae to show ...
Other Biology News:Singapore researchers first to transform carbon dioxide into methanol 2'First aid' for brain cells comes from blood 2UC Riverside researcher names lichen after President Barack Obama 2
... (CMV) pp65 Antigenemia Immunofluorescence Assay (IFA) is ... matrix protein pp65 of CMV in isolated ... Erythrocyte Lysis Buffer - ... mL of buffered ammonium chloride. (NH4CL) ...
... cell culture systems provide an ... cells for staining and imaging. ... gaskets preassembled with standard optical-quality ... The entire system is provided ...
nuclear cap binding protein subunit 1, 80kDa, mRNA...
GOAT ANTI SLI...
Biology Products: